Association of ERAP1 and IL23R gene polymorphisms with ankylosing spondylitis
https://doi.org/10.14412/1996-7012-2020-3-39-44
Abstract
Currently, the causes of extra-axial and extra-skeletal manifestations of ankylosing spondylitis (AS) and the possible impact of genetic aspects on its course and clinical features remain unresolved.
Objective: to investigate the association of the polymorphic markers rs10050860 and rs17482078 in the ERAP1 gene and rs11209026 in the IL23R gene with the development and clinical manifestations of AS.
Patients and methods. An allele-specific polymerase chain reaction assay was carried out to assess the alleles and corresponding genotypes of ERAP1 and IL23R gene polymorphisms in 70 patients (49 men and 21 women; mean age, 38 [31; 49] years) with AS and in 20 healthy donors. The activity indices, ESR, CRP, and extra-axial and extra-skeletal manifestations of AS were assessed in patients at the time of the investigation and in their history.
Results and discussion. The results of genotyping showed a significant association of the studied markers with AS. The carriage of the C/T genotype of the polymorphic markers rs10050860 and rs17482078 in the ERAP1 gene was associated with the history of peripheral arthritis (p=0.029) and the presence of incomplete right bundle branch block (IRBBB) (p=0.003 and p=0.006); the carriage of the G/A genotype of the marker rs11209026 in the IL23R gene was significantly associated with psoriasis (p=0.017) and IRBBB (p=0.03) in patients with AS.
Conclusion. The polymorphic markers of the ERAP1 and IL23R genes are associated with the risk of developing AS in this sample of patients. There is a significant correlation between the studied polymorphisms and some clinical manifestations of AS, which can be considered as a predictor of a more severe disease course.
About the Authors
U. A. Yakubova
Orenburg State Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
Uliana Andreevna Yakubova
6, Sovetskaya St., Orenburg, 460000
O. V. Bugrova
Orenburg State Medical University, Ministry of Health of Russia
Russian Federation
6, Sovetskaya St., Orenburg, 460000
Russian Federation
6, Sovetskaya St., Orenburg, 460000
K. A. Nagornova
Orenburg State Medical University, Ministry of Health of Russia
Russian Federation
6, Sovetskaya St., Orenburg, 460000
Russian Federation
6, Sovetskaya St., Orenburg, 460000
References
1. Erdes ShF, Rebrov AP, Dubinina TV, et al. Spondyloarthritis: modern terminology and definitions. Terapevticheskii arkhiv. 2019; 91(5):84–8. (In Russ.).
2. Erdes ShF, Bochkova AG, Dubinina TV, et al. Project of working classification of ankylosing spondylitis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2013;51(6):604-8. (In Russ.). doi: 10.14412/1995-4484-2013-604-8
3. Cherentsova IA, Otteva EN, Ostrovskii AB. New insights into Bekhterev''s disease. Zdravookhranenie Dal'nego Vostoka. 2016;67(1): 93-101. (In Russ.).
4. Baraliakos X, Braun J. Hip involvement in ankylosing spondylitis: what is the verdict? Rheumatology (Oxford). 2010 Jan;49(1):3-4. doi: 10.1093/rheumatology/kep298. Epub 2009 Sep 15.
5. Podryadnova MV, Balabanova RM, Urumova MM, Erdes ShF. Coxitis in ankylosing spondylitis: comparison of clinical manifestations with ultrasound study data. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2014;52(4):417-22. (In Russ.). doi: 10.14412/1995-4484-2014-417-422
6. Godzenko AA, Rumyantseva OA, Bochkova AG, et al. Extraskeletal manifestations and the indicators of inflammatory activity and severity in ankylosing spondylitis. Nauchnopraktichekaya revmatologiya = Rheumatology Science and Practice. 2017;55(2):169-76. (In Russ.). doi: 10.14412/1995-4484-2017169-176
7. Wellcome Trust Case Control Consortium1; Australo-Anglo-American Spondylitis Consortium (TASC), Burton PR, Clayton DG, Cardon LR, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 2007 Nov;39(11):1329-37. doi: 10.1038/ng.2007.17. Epub 2007 Oct 21.
8. Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007 Apr 21;369(9570):1379-90. doi: 10.1016/S0140-6736(07)60635-7.
9. Rahman P, Inman RD, Gladman DD, et al. Association of interleukin-23 receptor variants with ankylosing spondylitis. Arthritis Rheum. 2008 Apr;58(4):1020-5. doi: 10.1002/art.23389.
10. Harvey D, Pointon JJ, Evans DM, et al. Investigating the genetic association between ERAP1 and ankylosing spondylitis. Hum Mol Genet. 2009 Nov 1;18(21):4204-12. doi: 10.1093/hmg/ddp371. Epub 2009 Aug 18.
11. Australo-Anglo-American Spondyloarthritis Consortium (TASC), Reveille JD, Sims AM, Danoy P, et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet. 2010 Feb;42(2):123-7. doi: 10.1038/ng.513. Epub 2010 Jan 10.
12. Szczypiorska M, Sanchez A, Bartolome N, et al. ERAP1 polymorphisms and haplotypes are associated with ankylosing spondylitis susceptibility and functional severity in a Spanish population. Rheumatology (Oxford). 2011 Nov;50(11):1969-75. doi: 10.1093/rheumatology/ker229. Epub 2011 Aug 24.
13. Erdes ShF, Bochkova AG, Dubinina TV, et al. Early diagnosis of ankylosing spondylitis. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2013; 51(4):365-67. (In Russ.). doi: 10.14412/1995-4484-2013-124514.
14. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum. 1984 Apr;27(4):361-8. doi: 10.1002/art.1780270401.
15. Godzenko AА, Korsakova YuL, Badokin VV. Methods for the evaluation of inflammatory activity and therapy efficiency in spondyloarthritis. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2012;6(2): 66-76. (In Russ.). doi: 10.14412/1996-70122012-730
16. Calin A, Garrett S, Whitelock H, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol. 1994 Dec;21(12):2281-5.
17. Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, et al. Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis. 2003 Feb;62(2):127-32. doi: 10.1136/ard.62.2.127.
18. Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet. 2005 May; 76(5):887-93. doi: 10.1086/429864. Epub 2005 Mar 23.
19. Kochan G, Krojer T, Harvey D, et al. Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming. Proc Natl Acad Sci U S A. 2011 May 10; 108(19):7745-50. doi: 10.1073/pnas.1101262108. Epub 2011 Apr 20.
20. Reeves E, Colebatch-Bourn A, Elliott T, et al. Functionally distinct ERAP1 allotype combinations distinguish individuals with Ankylosing Spondylitis. Proc Natl Acad Sci U S A. 2014 Dec 9;111(49):17594-9. doi: 10.1073/pnas.1408882111. Epub 2014 Nov 24.
21. Zambrano-Zaragoza JF, Agraz-Cibrian JM, Gonzalez-Reyes C, et al. Ankylosing spondylitis: from cells to genes. Int J Inflam. 2013;2013:501653. doi: 10.1155/2013/501653. Epub 2013 Jul 21.
22. Murphy CA, Langrish CL, Chen Y, et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med. 2003 Dec 15; 198(12):1951-7. doi: 10.1084/jem.20030896. Epub 2003 Dec 8.
23. Raychaudhuri SP, Raychaudhuri SK. Mechanistic rationales for targeting interleukin-17A in spondyloarthritis. Arthritis Res Ther. 2017 Mar 8;19(1):51. doi: 10.1186/s13075-017-1249-5.
24. DeLay ML, Turner MJ, Klenk EI, et al. HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis Rheum. 2009 Sep; 60(9):2633-43. doi: 10.1002/art.24763.
25. Colbert RA, Tran TM, Layh-Schmitt G. HLA-B27 misfolding and ankylosing spondylitis. Mol Immunol. 2014 Jan;57(1): 44-51. doi: 10.1016/j.molimm.2013.07.013. Epub 2013 Aug 30.
Review
For citations:
Yakubova UA, Bugrova OV, Nagornova KA. Association of ERAP1 and IL23R gene polymorphisms with ankylosing spondylitis. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2020;14(3):39-44. https://doi.org/10.14412/1996-7012-2020-3-39-44
Views:
654
Email this article 